Characterization of a new pseudotyped HIV with a single-round infectivity carrying enhanced green fluorescent protein gene

Chinese Journal of Microbiology and Immunology

Volumn 26, Issue 5, 2006, Pages 394-398

  Qiu, Chao ^a   Peng, Hong ^b   Huang, Xiang Gang ^b   Ren, Li ^b   Pan, Xiang ^b   Shao, Yi Ming ^b   Xu, Jian Qing ^b  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b NONE

Author keywords

Green fluorescent protein; HIV; Neutralization antibody; Pseudovirus

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; ENHANCED GREEN FLUORESCENT PROTEIN; NEUTRALIZING ANTIBODY;

ARTICLE; FLUORESCENCE ACTIVATED CELL SORTING; GENE; GENE EXPRESSION; HUMAN IMMUNODEFICIENCY VIRUS; INFECTION; NONHUMAN; PLASMID; RESTRICTION MAPPING; VIRUS ENVELOPE; VIRUS GENE;

EID: 33747145593     PISSN: 02545101     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Dong M, Zhang PF, Grieder F, et al. Induction of primary virus-cross-reactive human immunodeficiency virus type 1-neutralizing antibodies in small animals by using an alphavirus-derived in vivo expression system. Proc Natl Acad Sci USA, 2003, 100(6): 3345-3350.
2. Jordan A, Bisgrove D, Verdin E. HIV reproducibly establishes a latent infection after acute infection of T cells in vitro. EMBO J, 2003, 22(8): 1868-1877.
3. Zhang H, Zhou Y, Alcock C, et al. Novel single-cell-level phenotypic assay for residual drug susceptibility and reduced replication capacity of drug-resistant human immunodeficiency virus type 1. J Virol, 2004, 78 (4): 1718-1729.
4. + T cells. J Exp Med, 2001, 194(10): 1407-1419.
5. He J, Choe S, Walker R, et al. Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. J Virol, 1995, 69: 6705-6711.
6. Deng HK, Liu R, Ellmeier W, et al. Identification of a major co-receptor for primary isolates of HIV-1. Nature, 1996, 381: 661-666.
7. Mascola JR, Louder MK, Winter C, et al. Human imnunodeficiency virus type 1 neutralization measured by flow cytometric quantitation of single-round infection of primary human T cells. J Virol, 2002, 76(10): 4810-4821.
8. + T lymphocytes. J Virol, 1992, 66(11): 6489-6495.
9. He J, Landau NR. Use of a novel human immunodeficiency virus type 1 reporter virus expressing human placental alkaline phoephatase to detect an alternative viral receptor. J Virol, 1995, 69(7): 4587-4592.
10. Chang LJ, Urlacher V, Iwakuma T, et al. Efficacy and safety analyses of a recombinant human immunodeficiency virus type 1 derived vector system. Gene Ther, 1999, 6(5): 715-728.
11. Gougeon ML. Apoptoeis as an HIV strategy to escape immune attack. Nat Rev Immunol, 2003, 3(5): 392-104.